drugset / Trial / NCT03335085

Oxytocin Administration and Emotion Recognition Abilities in Adults Reporting Adverse Childhood Experiences

NCT03335085

Non-randomizedCrossoverDouble-blindBasic science

Summary

This study evaluates whether intranasal administration of a single dose of oxytocin improves the ability to recognize emotional states. In a cross-over design, half of the participants first received oxytocin, the other half first received placebo.

Timeline

Start
2011-07-01
Primary completion
2013-03-23
Completion
2013-11-05

Drugs

EvaluationDrugModalityDoseRoute
Comparator Oxytocin Peptide 24 iu Intranasal

Indications

No indication recorded.